Fluorine in PDB 5a14: Human CDK2 with Type II Inhibitor
Enzymatic activity of Human CDK2 with Type II Inhibitor
All present enzymatic activity of Human CDK2 with Type II Inhibitor:
2.7.11.1;
2.7.11.22;
Protein crystallography data
The structure of Human CDK2 with Type II Inhibitor, PDB code: 5a14
was solved by
L.T.Alexander,
J.M.Elkins,
J.Kopec,
O.Fedorov,
P.A.Savitsky,
H.Moebitz,
S.W.Cowan-Jacob,
M.Szklarz,
A.C.W.Pike,
E.P.Carpenter,
T.Krojer,
C.Bountra,
A.M.Edwards,
S.Knapp,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
53.69 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
64.410,
67.270,
89.130,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.4 /
24
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human CDK2 with Type II Inhibitor
(pdb code 5a14). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human CDK2 with Type II Inhibitor, PDB code: 5a14:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 1 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1297
b:36.9
occ:1.00
|
F26
|
A:LQ51297
|
0.0
|
36.9
|
1.0
|
C25
|
A:LQ51297
|
1.4
|
35.5
|
1.0
|
F28
|
A:LQ51297
|
2.1
|
34.2
|
1.0
|
F27
|
A:LQ51297
|
2.2
|
36.9
|
1.0
|
C24
|
A:LQ51297
|
2.4
|
33.4
|
1.0
|
C23
|
A:LQ51297
|
3.1
|
32.0
|
1.0
|
CD2
|
A:HIS125
|
3.1
|
32.4
|
1.0
|
C30
|
A:LQ51297
|
3.2
|
33.0
|
1.0
|
C29
|
A:LQ51297
|
3.4
|
31.4
|
1.0
|
NE2
|
A:HIS125
|
3.5
|
31.9
|
1.0
|
O
|
A:ALA144
|
3.9
|
27.9
|
1.0
|
C
|
A:ALA144
|
3.9
|
29.3
|
1.0
|
C32
|
A:LQ51297
|
3.9
|
34.2
|
1.0
|
N31
|
A:LQ51297
|
4.1
|
35.4
|
1.0
|
N
|
A:ASP145
|
4.2
|
30.8
|
1.0
|
CG
|
A:HIS125
|
4.3
|
31.1
|
1.0
|
CA
|
A:ALA144
|
4.3
|
28.9
|
1.0
|
CB
|
A:ASP145
|
4.3
|
34.8
|
1.0
|
CB
|
A:LEU143
|
4.4
|
29.2
|
1.0
|
N
|
A:ALA144
|
4.4
|
28.3
|
1.0
|
C22
|
A:LQ51297
|
4.4
|
31.6
|
1.0
|
C
|
A:LEU143
|
4.5
|
28.3
|
1.0
|
C20
|
A:LQ51297
|
4.6
|
32.9
|
1.0
|
CE1
|
A:HIS125
|
4.6
|
32.5
|
1.0
|
O
|
A:LEU143
|
4.8
|
29.2
|
1.0
|
CA
|
A:ASP145
|
4.9
|
33.4
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 2 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1297
b:36.9
occ:1.00
|
F27
|
A:LQ51297
|
0.0
|
36.9
|
1.0
|
C25
|
A:LQ51297
|
1.4
|
35.5
|
1.0
|
F28
|
A:LQ51297
|
2.2
|
34.2
|
1.0
|
F26
|
A:LQ51297
|
2.2
|
36.9
|
1.0
|
C24
|
A:LQ51297
|
2.4
|
33.4
|
1.0
|
C23
|
A:LQ51297
|
3.0
|
32.0
|
1.0
|
C30
|
A:LQ51297
|
3.0
|
33.0
|
1.0
|
C29
|
A:LQ51297
|
3.5
|
31.4
|
1.0
|
CD1
|
A:LEU58
|
3.5
|
32.6
|
1.0
|
CG2
|
A:ILE63
|
3.7
|
31.7
|
1.0
|
C22
|
A:LQ51297
|
4.3
|
31.6
|
1.0
|
N31
|
A:LQ51297
|
4.4
|
35.4
|
1.0
|
CB
|
A:LEU58
|
4.6
|
32.8
|
1.0
|
CD1
|
A:ILE63
|
4.7
|
36.6
|
1.0
|
C20
|
A:LQ51297
|
4.7
|
32.9
|
1.0
|
SG
|
A:CYS118
|
4.7
|
32.9
|
1.0
|
CG
|
A:LEU58
|
4.7
|
32.7
|
1.0
|
C32
|
A:LQ51297
|
4.9
|
34.2
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 3 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1297
b:34.2
occ:1.00
|
F28
|
A:LQ51297
|
0.0
|
34.2
|
1.0
|
C25
|
A:LQ51297
|
1.3
|
35.5
|
1.0
|
F26
|
A:LQ51297
|
2.1
|
36.9
|
1.0
|
F27
|
A:LQ51297
|
2.2
|
36.9
|
1.0
|
C24
|
A:LQ51297
|
2.4
|
33.4
|
1.0
|
C29
|
A:LQ51297
|
2.8
|
31.4
|
1.0
|
O
|
A:LEU143
|
3.2
|
29.2
|
1.0
|
CA
|
A:ALA144
|
3.4
|
28.9
|
1.0
|
C
|
A:LEU143
|
3.5
|
28.3
|
1.0
|
CG2
|
A:ILE63
|
3.6
|
31.7
|
1.0
|
N
|
A:ALA144
|
3.7
|
28.3
|
1.0
|
C23
|
A:LQ51297
|
3.7
|
32.0
|
1.0
|
C
|
A:ALA144
|
3.8
|
29.3
|
1.0
|
CG1
|
A:VAL64
|
4.0
|
30.6
|
1.0
|
CB
|
A:LEU143
|
4.1
|
29.2
|
1.0
|
N
|
A:ASP145
|
4.2
|
30.8
|
1.0
|
C20
|
A:LQ51297
|
4.2
|
32.9
|
1.0
|
O
|
A:ALA144
|
4.3
|
27.9
|
1.0
|
O39
|
A:LQ51297
|
4.3
|
29.7
|
1.0
|
C30
|
A:LQ51297
|
4.4
|
33.0
|
1.0
|
CA
|
A:LEU143
|
4.5
|
28.3
|
1.0
|
N
|
A:VAL64
|
4.7
|
29.9
|
1.0
|
CB
|
A:ALA144
|
4.7
|
30.3
|
1.0
|
CB
|
A:ILE63
|
4.8
|
31.9
|
1.0
|
CD2
|
A:LEU55
|
4.8
|
33.5
|
1.0
|
C22
|
A:LQ51297
|
4.9
|
31.6
|
1.0
|
CD2
|
A:HIS125
|
5.0
|
32.4
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 4 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1298
b:44.7
occ:1.00
|
F26
|
A:LQ51298
|
0.0
|
44.7
|
1.0
|
C25
|
A:LQ51298
|
1.4
|
44.7
|
1.0
|
F28
|
A:LQ51298
|
2.2
|
42.8
|
1.0
|
F27
|
A:LQ51298
|
2.2
|
49.6
|
1.0
|
C24
|
A:LQ51298
|
2.5
|
42.4
|
1.0
|
C29
|
A:LQ51298
|
2.8
|
38.2
|
1.0
|
C23
|
A:LQ51298
|
3.8
|
41.7
|
1.0
|
CE2
|
A:PHE213
|
4.1
|
35.5
|
1.0
|
C20
|
A:LQ51298
|
4.2
|
39.4
|
1.0
|
O39
|
A:LQ51298
|
4.4
|
38.8
|
1.0
|
CD2
|
A:PHE213
|
4.5
|
34.2
|
1.0
|
C30
|
A:LQ51298
|
4.5
|
41.5
|
1.0
|
C22
|
A:LQ51298
|
4.9
|
40.9
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 5 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1298
b:49.6
occ:1.00
|
F27
|
A:LQ51298
|
0.0
|
49.6
|
1.0
|
C25
|
A:LQ51298
|
1.4
|
44.7
|
1.0
|
F26
|
A:LQ51298
|
2.2
|
44.7
|
1.0
|
F28
|
A:LQ51298
|
2.2
|
42.8
|
1.0
|
C24
|
A:LQ51298
|
2.4
|
42.4
|
1.0
|
C23
|
A:LQ51298
|
3.1
|
41.7
|
1.0
|
C30
|
A:LQ51298
|
3.1
|
41.5
|
1.0
|
C29
|
A:LQ51298
|
3.6
|
38.2
|
1.0
|
N31
|
A:LQ51298
|
4.4
|
42.9
|
1.0
|
C22
|
A:LQ51298
|
4.4
|
40.9
|
1.0
|
C32
|
A:LQ51298
|
4.7
|
42.5
|
1.0
|
C20
|
A:LQ51298
|
4.8
|
39.4
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5a14
Go back to
Fluorine Binding Sites List in 5a14
Fluorine binding site 6 out
of 6 in the Human CDK2 with Type II Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1298
b:42.8
occ:1.00
|
F28
|
A:LQ51298
|
0.0
|
42.8
|
1.0
|
C25
|
A:LQ51298
|
1.4
|
44.7
|
1.0
|
F26
|
A:LQ51298
|
2.2
|
44.7
|
1.0
|
F27
|
A:LQ51298
|
2.2
|
49.6
|
1.0
|
C24
|
A:LQ51298
|
2.3
|
42.4
|
1.0
|
C23
|
A:LQ51298
|
3.1
|
41.7
|
1.0
|
C30
|
A:LQ51298
|
3.2
|
41.5
|
1.0
|
C29
|
A:LQ51298
|
3.4
|
38.2
|
1.0
|
C32
|
A:LQ51298
|
3.6
|
42.5
|
1.0
|
CH2
|
A:TRP243
|
4.0
|
40.3
|
1.0
|
N31
|
A:LQ51298
|
4.0
|
42.9
|
1.0
|
CZ2
|
A:TRP243
|
4.0
|
41.4
|
1.0
|
CB
|
A:PRO241
|
4.2
|
40.0
|
1.0
|
C22
|
A:LQ51298
|
4.3
|
40.9
|
1.0
|
C20
|
A:LQ51298
|
4.6
|
39.4
|
1.0
|
CG
|
A:PRO241
|
4.6
|
38.7
|
1.0
|
CD2
|
A:PHE213
|
4.8
|
34.2
|
1.0
|
CE2
|
A:PHE213
|
4.9
|
35.5
|
1.0
|
C21
|
A:LQ51298
|
5.0
|
37.6
|
1.0
|
|
Reference:
L.T.Alexander,
H.Mobitz,
P.Drueckes,
P.Savitsky,
O.Fedorov,
J.M.Elkins,
C.M.Deane,
S.W.Cowan-Jacob,
S.Knapp.
Type II Inhibitors Targeting CDK2. Acs Chem.Biol. V. 10 2116 2015.
ISSN: ISSN 1554-8929
PubMed: 26158339
DOI: 10.1021/ACSCHEMBIO.5B00398
Page generated: Thu Aug 1 07:34:19 2024
|